Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 13Head & Neck 3Dermatologic 3Tumor-Agnostic 2Thoracic 2Other hematologic neoplasm 2Gastrointestinal 2Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Uveal Melanoma 1Melanoma 1Keratosis, Actinic 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Melatonin × Dermatologic × Clear all
NCT05502900 2025-05-15

AMUM

St. Erik Eye Hospital

Phase 3 Recruiting
100 enrolled
Dermatologic

Uveal Melanoma

NCT05740969 2023-02-23

PACKS

Zealand University Hospital

Phase 2 Unknown
48 enrolled
Dermatologic

Keratosis, Actinic

NCT02190838 2019-11-25

Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma

N.N. Petrov National Medical Research Center of Oncology

Phase 2 Terminated
57 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡